Pharmacy Benefits Management Services Home

Average doses from clinical trials were approximately 9-11 ng/kg/min at 12 weeks, but maintenance doses vary widely between patients and tend to increase over time. Due to the safety concerns with central venous catheterization and readily observable side effects of the drug, clinical trials with epoprostenol have been conducted in an open ... ................
................